当前位置:首页 - 行情中心 - 第一医药(600833) - 财务分析 - 现金流量表

第一医药

(600833)

  

流通市值:28.73亿  总市值:28.73亿
流通股本:2.23亿   总股本:2.23亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,652,800,908.611,105,853,639.48581,240,238.592,089,670,023.24
  收到的税费返还9,023,181.955,767,087.55--
  收到其他与经营活动有关的现金27,038,213.2517,174,274.524,839,016.5351,301,800.02
  经营活动现金流入小计1,688,862,303.811,128,795,001.55586,079,255.122,140,971,823.26
  购买商品、接受劳务支付的现金1,327,757,284.68847,728,800.66457,078,645.981,673,237,037.26
  支付给职工以及为职工支付的现金95,238,687.0181,494,456.5945,703,276.21188,622,282.43
  支付的各项税费34,630,124.0323,890,347.2112,958,383.27104,141,858.12
  支付其他与经营活动有关的现金206,694,586.57120,145,508.0157,642,494.14125,943,299.91
  经营活动现金流出小计1,664,320,682.291,073,259,112.47573,382,799.62,091,944,477.72
  经营活动产生的现金流量净额24,541,621.5255,535,889.0812,696,455.5249,027,345.54
二、投资活动产生的现金流量:
  收回投资收到的现金265,000,000255,000,000220,000,000338,600,000
  取得投资收益收到的现金15,251,507.6815,132,773.917,190,813.79,460,485.84
  处置固定资产、无形资产和其他长期资产收回的现金净额54,091,026.1189,772.2856,755.62183,716,026.88
  投资活动现金流入小计334,342,533.79270,222,546.19227,247,569.32531,776,512.72
  购建固定资产、无形资产和其他长期资产支付的现金12,789,546.097,346,816.864,437,042.0151,937,795.99
  投资支付的现金314,700,000299,700,000209,700,000404,476,666.65
  投资活动现金流出小计327,489,546.09307,046,816.86214,137,042.01456,414,462.64
  投资活动产生的现金流量净额6,852,987.7-36,824,270.6713,110,527.3175,362,050.08
三、筹资活动产生的现金流量:
  吸收投资收到的现金---1,470,000
  其中:子公司吸收少数股东投资收到的现金---1,470,000
  取得借款收到的现金99,289,263.8949,636,541.67-144,047,200.01
  筹资活动现金流入平衡项目00-0
  筹资活动现金流入小计99,289,263.8949,636,541.67-145,517,200.01
  偿还债务支付的现金94,647,033.3494,647,033.3435,800,900144,471,250
  分配股利、利润或偿付利息支付的现金51,138,926.331,716,424.99199,10029,413,145.27
  支付其他与筹资活动有关的现金44,591,269.7230,259,376.3116,003,720.0667,344,586.71
  筹资活动现金流出小计190,377,229.39126,622,834.6452,003,720.06241,228,981.98
  筹资活动产生的现金流量净额-91,087,965.5-76,986,292.97-52,003,720.06-95,711,781.97
四、汇率变动对现金及现金等价物的影响-560,726.39-127,454.0840,469.38464,401.8
五、现金及现金等价物净增加额-60,254,082.67-58,402,128.64-26,156,267.8529,142,015.45
  加:期初现金及现金等价物余额428,870,007.92428,870,007.92428,870,007.92399,727,992.47
  期末现金及现金等价物余额368,615,925.25370,467,879.28402,713,740.07428,870,007.92
补充资料:
  净利润-14,321,865.08-163,615,358.96
  资产减值准备---4,789,484.62
  固定资产和投资性房地产折旧-2,505,200.94-4,169,048.2
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-2,505,200.94-4,169,048.2
  无形资产摊销-1,543,689.87-3,335,978.74
  长期待摊费用摊销-3,588,850.95-6,366,923.89
  处置固定资产、无形资产和其他长期资产的损失--404,944.23--169,176,202.55
  固定资产报废损失-100,042.1-288,790.52
  公允价值变动损失----379,109.59
  财务费用-2,309,009.74-6,229,982.45
  投资损失--8,489,595.84--12,905,483.23
  递延所得税--6,235,982.23-4,287,198.34
  其中:递延所得税资产减少--7,801,192.83-2,034,540.91
    递延所得税负债增加-1,565,210.6-2,252,657.43
  存货的减少--49,747,752.13--3,887,023.6
  经营性应收项目的减少--59,122,085.75-50,128,678.56
  经营性应付项目的增加-128,097,996.78--42,754,339.26
  现金的期末余额-370,467,879.28-428,870,007.92
  减:现金的期初余额-428,870,007.92-399,727,992.47
  现金及现金等价物的净增加额--58,402,128.64-29,142,015.45
公告日期2025-10-312025-08-202025-04-302025-04-09
审计意见(境内)标准无保留意见
TOP↑